GLPG
Galapagos N.V.NASDAQHealthcare$29.42-0.07%ClosedMarket Cap: $1.94B
As of 2026-04-06
Valuation
P/E (TTM)
6.04
PEG
0.02
P/B
0.52
P/S
1.52
EV/EBITDA
3.66
DCF Value
$5.39
FCF Yield
-15.8%
Div Yield
0.0%
Margins & Returns
Gross Margin
97.3%
Operating Margin
43.6%
Net Margin
28.8%
ROE
11.2%
ROA
9.4%
ROIC
14.9%
Income Statement
| Period | Revenue | Gross Margin | Operating Income | Net Income | EPS | Dividend |
|---|---|---|---|---|---|---|
| Q4 2025 | $900.8M | 49.0% | $913.3M | $782.2M | $11.76 | — |
| FY 2025 | $1.11B | 89.0% | $451.1M | $320.9M | $4.85 | — |
| Q3 2025 | $71.2M | 84.8% | $-246.4M | $-202.1M | $-3.10 | — |
| Q2 2025 | $65.3M | 92.8% | $-57.0M | $-105.7M | $-1.61 | — |
| Q1 2025 | $75.0M | 81.7% | $-158.7M | $-153.4M | $-2.33 | — |
| Q4 2024 | $75.5M | -49.6% | $-62.7M | $25.3M | $0.29 | — |
| FY 2024 | $275.6M | 87.4% | $-188.3M | $74.1M | $1.12 | — |
| Q3 2024 | $59.8M | 100.0% | $-54.3M | $-50.4M | $-0.74 | — |
| Q2 2024 | $77.9M | 78.7% | $-38.2M | $9.0M | $0.14 | — |
| Q1 2024 | $62.4M | 95.9% | $-33.1M | $90.2M | $1.37 | — |
| Q4 2023 | $-209.1M | 100.0% | $-69.3M | $157.6M | $-0.88 | — |
| FY 2023 | $239.7M | 100.0% | $-88.3M | $211.7M | $-0.06 | — |